Patents by Inventor Brihad Abhyankar

Brihad Abhyankar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240009270
    Abstract: The present invention relates to methods of treating or preventing AIBD.
    Type: Application
    Filed: June 9, 2023
    Publication date: January 11, 2024
    Applicant: VOLUTION IMMUNO PHARMACEUTICALS SA
    Inventors: Miles Nunn, Brihad Abhyankar, Christian David Sadik
  • Patent number: 11730792
    Abstract: The present invention relates to methods of treating or preventing AIBD.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: August 22, 2023
    Assignee: Volution Immuno Pharmaceuticals SA
    Inventors: Miles Andrew Nunn, Brihad Abhyankar, Christian David Sadik
  • Patent number: 11596688
    Abstract: The invention provides methods for treating patients with anti-?4?7 antibody comprising predicting outcome of the antibody therapy. The invention relates to the identification of patients who can respond to therapy comprising an anti-?4?7 antibody.
    Type: Grant
    Filed: June 27, 2019
    Date of Patent: March 7, 2023
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Maria Rosario, Timothy L. Wyant, Brihad Abhyankar
  • Publication number: 20210388092
    Abstract: Disclosed is a method for treating a subject having primary sclerosing cholangitis, comprising administering to said subject an effective amount of a humanized antibody or antigen-binding fragment thereof having binding specificity for ?4?7 integrin.
    Type: Application
    Filed: February 24, 2021
    Publication date: December 16, 2021
    Inventor: Brihad Abhyankar
  • Publication number: 20200155673
    Abstract: The invention provides methods for treating patients with anti-?4?7 antibody comprising predicting outcome of the antibody therapy. The invention relates to the identification of patients who can respond to therapy comprising an anti-?4?7 antibody.
    Type: Application
    Filed: June 27, 2019
    Publication date: May 21, 2020
    Inventors: Maria ROSARIO, Timothy L. WYANT, Brihad Abhyankar
  • Publication number: 20200113971
    Abstract: The present invention relates to methods of treating or preventing AIBD.
    Type: Application
    Filed: April 20, 2018
    Publication date: April 16, 2020
    Applicant: VOLUTION IMMUNO PHARMACEUTICALS SA
    Inventors: Miles Andrew Nunn, Brihad Abhyankar, Christian David Sadik
  • Publication number: 20180051086
    Abstract: Disclosed is a method for treating a subject having primary sclerosing cholangitis, comprising administering to said subject an effective amount of a humanized antibody or antigen-binding fragment thereof having binding specificity for alpha 4 beta 7 integrin.
    Type: Application
    Filed: March 4, 2016
    Publication date: February 22, 2018
    Applicants: Takeda Development Centre Europe Ltd., Takeda Pharmaceutical Company Limited, Millennium Pharmaceuticals, Inc.
    Inventor: Brihad ABHYANKAR
  • Publication number: 20170360926
    Abstract: The invention provides methods for treating patients with anti-?4?7 antibody comprising predicting outcome of the antibody therapy. The invention relates to the identification of patients who can respond to therapy comprising an anti-a4?7 antibody.
    Type: Application
    Filed: December 23, 2015
    Publication date: December 21, 2017
    Inventors: Maria Rosario, Timothy L. Wyant, Brihad Abhyankar